Reuters logo
BRIEF-Amgen announces new analyses of high-risk patient subgroups
2017年11月6日 / 下午2点28分 / 16 天前

BRIEF-Amgen announces new analyses of high-risk patient subgroups

Nov 6 (Reuters) - Amgen Inc:

* Announces new analyses of high-risk patient subgroups from Repatha (evolocumab) cardiovascular outcomes study at AHA Scientific Sessions 2017 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below